Q5138 Injection, wezlana, intravenous, 1 milligrams
Also known as: Wezlana intravenous, anifrolumab-fnia
Injection of Wezlana, anifrolumab-fnia biosimilar intravenous per 1 milligram, for systemic lupus erythematosus.
In Plain Language
intravenous lupus treatment; immune suppressing infusion
Clinical Context
Used for active systemic lupus erythematosus and lupus nephritis requiring intravenous therapy.
RVU Information
CPT Q5138 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5138?
CPT Q5138 (Injection, wezlana, intravenous, 1 milligrams) is a Q Codes code. Injection of Wezlana, anifrolumab-fnia biosimilar intravenous per 1 milligram, for systemic lupus erythematosus.
Is Q5138 covered by insurance?
Q5138 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for active systemic lupus erythematosus and lupus nephritis requiring intravenous therapy.
When is CPT Q5138 used?
Used for active systemic lupus erythematosus and lupus nephritis requiring intravenous therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.